201 related articles for article (PubMed ID: 8099762)
1. Differential pharmacological profile of striatal and cerebellar dopamine receptors labeled by [3H]quinpirole: identification of a discrete population of putative D3 receptors.
Levant B; DeSouza EB
Synapse; 1993 May; 14(1):90-5. PubMed ID: 8099762
[TBL] [Abstract][Full Text] [Related]
2. [3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study.
Levant B; Grigoriadis DE; DeSouza EB
J Pharmacol Exp Ther; 1993 Feb; 264(2):991-1001. PubMed ID: 8437136
[TBL] [Abstract][Full Text] [Related]
3. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
Levant B; Grigoriadis DE; DeSouza EB
J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
[TBL] [Abstract][Full Text] [Related]
4. Relative affinities of dopaminergic drugs at dopamine D2 and D3 receptors.
Levant B; Grigoriadis DE; De Souza EB
Eur J Pharmacol; 1995 May; 278(3):243-7. PubMed ID: 7589161
[TBL] [Abstract][Full Text] [Related]
5. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
Gackenheimer SL; Schaus JM; Gehlert DR
J Pharmacol Exp Ther; 1995 Sep; 274(3):1558-65. PubMed ID: 7562534
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of [3H]R(+)-7-OH-DPAT binding in the rat caudate-putamen.
Hillefors M; von Euler G
Neurochem Int; 2001 Jan; 38(1):31-42. PubMed ID: 10913686
[TBL] [Abstract][Full Text] [Related]
7. Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine.
Janowsky A; Neve KA; Kinzie JM; Taylor B; de Paulis T; Belknap JK
J Pharmacol Exp Ther; 1992 Jun; 261(3):1282-90. PubMed ID: 1534844
[TBL] [Abstract][Full Text] [Related]
8. Modulation of [3H]quinpirole binding in brain by monoamine oxidase inhibitors: evidence for a potential novel binding site.
Levant B; Moehlenkamp JD; Morgan KA; Leonard NL; Cheng CC
J Pharmacol Exp Ther; 1996 Jul; 278(1):145-53. PubMed ID: 8764345
[TBL] [Abstract][Full Text] [Related]
9. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
Zahniser NR; Dubocovich ML
J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
[TBL] [Abstract][Full Text] [Related]
10. Expression and pharmacological characterization of the human D3 dopamine receptor.
Freedman SB; Patel S; Marwood R; Emms F; Seabrook GR; Knowles MR; McAllister G
J Pharmacol Exp Ther; 1994 Jan; 268(1):417-26. PubMed ID: 8301582
[TBL] [Abstract][Full Text] [Related]
11. Cerebellar and striatal dopamine receptors: effects of reeler and weaver murine mutations.
Panagopoulos NT; Matsokis NA; Valcana T
J Neurosci Res; 1993 Aug; 35(5):499-506. PubMed ID: 8377223
[TBL] [Abstract][Full Text] [Related]
12. Selective cortical infarction reduces [3H]sulpiride binding in rat caudate-putamen: autoradiographic evidence for presynaptic D2 receptors on corticostriate terminals.
Filloux F; Liu TH; Hsu CY; Hunt MA; Wamsley JK
Synapse; 1988; 2(5):521-31. PubMed ID: 2973146
[TBL] [Abstract][Full Text] [Related]
13. Characterization of [3H]quinpirole binding to human dopamine D2A and D3 receptors: effects of ions and guanine nucleotides.
Malmberg A; Mohell N
J Pharmacol Exp Ther; 1995 Aug; 274(2):790-7. PubMed ID: 7636742
[TBL] [Abstract][Full Text] [Related]
14. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
Leff SE; Creese I
Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
[TBL] [Abstract][Full Text] [Related]
15. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G
Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740
[TBL] [Abstract][Full Text] [Related]
16. Binding of [3H]PD 128907, a putatively selective ligand for the D3 dopamine receptor, in rat brain: a receptor binding and quantitative autoradiographic study.
Bancroft GN; Morgan KA; Flietstra RJ; Levant B
Neuropsychopharmacology; 1998 Apr; 18(4):305-16. PubMed ID: 9509498
[TBL] [Abstract][Full Text] [Related]
17. Quantitative autoradiography of Gpp(NH)p sensitive and insensitive [3H]quinpirole binding sites in the rat brain.
Gehlert DR
Synapse; 1993 Jun; 14(2):113-20. PubMed ID: 8101393
[TBL] [Abstract][Full Text] [Related]
18. Differential localization of dopamine D1 and D2 receptors in rat retina.
Tran VT; Dickman M
Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1620-6. PubMed ID: 1532792
[TBL] [Abstract][Full Text] [Related]
19. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
Audinot V; Newman-Tancredi A; Gobert A; Rivet JM; Brocco M; Lejeune F; Gluck L; Desposte I; Bervoets K; Dekeyne A; Millan MJ
J Pharmacol Exp Ther; 1998 Oct; 287(1):187-97. PubMed ID: 9765337
[TBL] [Abstract][Full Text] [Related]
20. Dopamine receptors labelled by [3H]quinpirole.
Seeman P; Schaus JM
Eur J Pharmacol; 1991 Oct; 203(1):105-9. PubMed ID: 1686763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
